October 9, 2025
Physician-scientist with experience spanning biomarker development and regulatory submissions joins to expand Tapestri’s reach to guide therapeutic insights SOUTH SAN FRANCISCO, Calif. -- Mission Bio, a leader in single-cell multi-omics for precision medicine, today announced the appointment of Zivjena Vucetic, M.D., Ph.D., as Chief Medical Officer. A physician-scientist with more than 15 years of experience [...]
Parse Biosciences Invalidates Scale Biosciences (now 10x Genomics) Patent
October 9, 2025
SEATTLE -- Parse Biosciences, a leading provider of accessible and scalable single cell sequencing solutions, today announced that the District Court for the District of Delaware has granted Parse’s Motion for Summary Judgment of Invalidity for Scale Biosciences’ 11,634,752 patent. The Court concluded that the claims of the ‘752 patent were invalid for lack of [...]
October 9, 2025
Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, today announced the launch of the NULISAqpcr™ BD-pTau217 Assay— a transformative leap in blood-based quantification of brain-derived phosphorylated tau 217 (pTau217)—a pivotal biomarker in Alzheimer’s disease research and other tauopathies. This first-of-its-kind assay is the only brain-derived single-plex solution available, setting a [...]
Volta Labs Launches Automated Twist Hybridization Capture Workflow on Callisto
October 9, 2025
BOSTON -- Volta Labs, the pioneer in next-generation sequencing (NGS) sample preparation solutions, today announced the launch of Hybridization Capture App for the Twist Standard Hybridization v2 Kit on Callisto. Volta Labs, a genomics applications company, is transforming the way biological research and analyses are performed with a cutting-edge digital fluidics platform to maximize performance [...]
October 9, 2025
Collaboration Will Bring Advanced Technologies to Customers More Quickly and Efficiently VIENNA -- Ribbon Bio and Scala Biodesign, two emerging leaders in biotechnology, both led by women CEOs, have announced a new business collaboration focused on better delivering to customers enzymes that enable more powerful DNA synthesis. The companies are combining their expertise in DNA [...]
October 8, 2025
Renishaw unveils the Strada® Intelligent Raman Microscope: A leap forward in user-friendly, high-performance chemical analysis Renishaw, a global leader in engineering and scientific technology, proudly announces the launch of its latest innovation—the Strada® Intelligent Raman Microscope. This new system combines the exceptional optical performance and chemical discrimination of research-grade Raman microscopes with an intuitive, user-friendly [...]
October 8, 2025
Lab equipment scheduling platform supporting pharma and life sciences R&D organisations’ AI journey amidst industry upheaval LONDON--Clustermarket, the lab equipment scheduling platform, has today announced it is rebranding to Calira and welcoming non-executive director and investor Edmund Wilson, co-founder and former CEO of Titian Software (now Cenevo), to capitalise on increasing enterprise demand for optimising [...]
October 8, 2025
CAMBRIDGE, England – biomodal, an omics-based life sciences technology and analytics company, today announced it has launched a Certified Service Provider (CSP) program with partners around the globe to meet the increasing demand for its novel duet multiomics solutions. The organizations are partnering with biomodal as they work to deliver transformative data and insights for [...]
Tempus Joins Parse Biosciences’ Certified Service Provider Network
October 8, 2025
Advancing multi-omics research by enabling Tempus’ data-driven expertise with Parse’s scalable single cell platform Parse Biosciences, the leader in scalable and accessible single cell sequencing, is pleased to welcome Tempus as the newest member of its Certified Service Provider (CSP) Program. Together, the companies will broaden access to high-quality and scalable single cell and empower [...]
October 8, 2025
The license will provide Sanofi scientists worldwide access to BenchSci’s ASCEND platform, which aims to accelerate drug discovery across multiple therapeutic areas. TORONTO—BenchSci, a world leader in AI solutions for preclinical research and drug discovery, today announced a three-year agreement with Sanofi to deploy and use BenchSci’s ASCEND™ platform across Sanofi’s global preclinical research organization. [...]

